Michael J. Kelley, MD
Potential Conflicts of Interest: None disclosed.
Kelley MJ. Surveillance for Hepatocellular Carcinoma. Ann Intern Med. 2011;155:274. doi: 10.7326/0003-4819-155-4-201108160-00016
Download citation file:
Published: Ann Intern Med. 2011;155(4):274.
TO THE EDITOR:
In their article, Davila and colleagues (1) examined administrative data in the Veterans Health Administration and observed low rates of screening for hepatocellular carcinoma (HCC) in patients during the first 4 years after cirrhosis diagnosis. They concluded that new strategies are needed to improve the implementation of HCC surveillance in clinical practice.
No randomized, controlled trials (RCTs) support screening for HCC among persons with hepatitis C virus infection and cirrhosis. Neither the U.S. Preventive Services Task Force nor the National Cancer Institute has recommended such screening, and the Veterans Health Administration has not adopted a practice guideline recommending screening for HCC in any population.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only